Does ENCORAFENIB Cause Muscular weakness? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Muscular weakness have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.6% of all adverse event reports for ENCORAFENIB.
48
Reports of Muscular weakness with ENCORAFENIB
0.6%
of all ENCORAFENIB reports
11
Deaths
23
Hospitalizations
How Dangerous Is Muscular weakness From ENCORAFENIB?
Of the 48 reports, 11 (22.9%) resulted in death, 23 (47.9%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENCORAFENIB. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which ENCORAFENIB Alternatives Have Lower Muscular weakness Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN